This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback
Trial record 1 of 1 for:    01461915
Previous Study | Return to List | Next Study

Efficacy & Safety of ODSH (2-0, 3-0 Desulfated Heparin) in Patients With Metastatic Pancreatic Cancer Treated With Gemcitabine & Abraxane (PGPC1)

This study has been completed.
Sponsor:
Collaborator:
Translational Drug Development
Information provided by (Responsible Party):
Cantex Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01461915
First received: October 13, 2011
Last updated: August 25, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2015
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: August 24, 2016